Welltower Inc., a Healthcare Real Estate Investment Trust (REIT), recently acquired a 23-property medical office portfolio from the Milwaukee-based private equity firm, Hammes Partners, for $400 million.
Spanning across a whopping 979,000 square feet, the portfolio is spread across 12 metro markets in Virginia, Washington, North Carolina, Illinois, New York, New Jersey, Pennsylvania, Alabama, and Texas and consists of outpatient properties affiliated with healthcare systems and other providers.
Consisting of ~3.3 million rentable square feet in major metropolitan markets across 16 states, the sale is expected to close by the first half of 2019. However, it is subject to customary closing conditions.
Jones Lang Lasalle Inc. (JLL), global real estate services firm specializing in commercial property and investment management, handled the sale for Hammes Partners.
Be on the lookout for a price bounce soon.
WELL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WELL as a result. In 27 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 35%.
The Moving Average Convergence Divergence Histogram (MACD) for WELL turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 16 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 39%.
WELL moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for WELL crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 29%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
The Aroon Indicator for WELL entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.617) is normal, around the industry mean (3.199). WELL has a moderately high P/E Ratio (104.466) as compared to the industry average of (44.369). WELL's Projected Growth (PEG Ratio) (3.660) is slightly higher than the industry average of (1.649). WELL has a moderately low Dividend Yield (0.013) as compared to the industry average of (0.053). WELL's P/S Ratio (13.316) is slightly higher than the industry average of (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines